19th Jun 2020 15:38
FORM 8.3
Amendment to Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 17 June 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
1,263,990 | 0.98% | 620,755 | 0.48% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
601,000 | 0.47% | 395,159 | 0.31% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
(4) | TOTAL: |
|
|
|
|
1,864,990 | 1.45% | 1,015,914 | 0.79% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 14 | 191.5400 USD |
| Purchase | 14 | 197.0329 USD |
| Purchase | 24 | 198.2250 USD |
| Purchase | 30 | 198.6200 USD |
| Purchase | 50 | 192.4300 USD |
| Purchase | 154 | 191.6300 USD |
| Purchase | 248 | 198.2283 USD |
| Purchase | 504 | 197.4037 USD |
| Purchase | 600 | 194.7145 USD |
| Purchase | 1,003 | 197.6359 USD |
| Purchase | 1,113 | 198.6571 USD |
| Purchase | 1,506 | 198.1109 USD |
| Purchase | 2,288 | 197.3536 USD |
| Purchase | 2,306 | 197.2087 USD |
| Purchase | 2,502 | 197.9469 USD |
| Purchase | 3,063 | 196.8222 USD |
| Purchase | 3,463 | 197.7956 USD |
| Purchase | 3,900 | 198.0494 USD |
| Purchase | 4,066 | 197.3802 USD |
| Purchase | 4,100 | 198.0371 USD |
| Purchase | 4,761 | 197.5952 USD |
| Purchase | 4,900 | 197.8262 USD |
| Purchase | 6,784 | 197.3500 USD |
| Purchase | 7,800 | 198.0116 USD |
| Purchase | 9,700 | 197.8890 USD |
| Purchase | 18,460 | 198.6845 USD |
| Purchase | 28,124 | 197.6741 USD |
| Purchase | 41,978 | 197.6392 USD |
| Sale | 14 | 197.0328 USD |
| Sale | 14 | 191.5400 USD |
| Sale | 24 | 198.2250 USD |
| Sale | 100 | 198.6700 USD |
| Sale | 100 | 192.3500 USD |
| Sale | 154 | 191.6300 USD |
| Sale | 197 | 193.2958 USD |
| Sale | 200 | 198.1290 USD |
| Sale | 295 | 198.6661 USD |
| Sale | 350 | 198.6120 USD |
| Sale | 410 | 197.4187 USD |
| Sale | 469 | 197.5888 USD |
| Sale | 500 | 197.9920 USD |
| Sale | 511 | 197.2169 USD |
| Sale | 550 | 198.7331 USD |
| Sale | 1,050 | 198.7161 USD |
| Sale | 1,300 | 198.7119 USD |
| Sale | 1,550 | 198.6874 USD |
| Sale | 1,894 | 198.6245 USD |
| Sale | 2,035 | 197.9632 USD |
| Sale | 2,167 | 197.7805 USD |
| Sale | 2,200 | 198.5997 USD |
| Sale | 2,200 | 198.6967 USD |
| Sale | 2,850 | 197.8214 USD |
| Sale | 2,946 | 197.0017 USD |
| Sale | 3,502 | 197.6238 USD |
| Sale | 6,710 | 197.9294 USD |
| Sale | 6,850 | 197.9171 USD |
| Sale | 6,971 | 198.7138 USD |
| Sale | 12,154 | 197.3500 USD |
| Sale | 34,919 | 197.6013 USD |
| Sale | 58,430 | 197.7608 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 19 Jun 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20200619005328/en/
Copyright Business Wire 2020
Related Shares:
Barclays